9th Circ. Revives Takeda Buyers' RICO Suit Over Actos Risk
The Ninth Circuit ruled Tuesday that Takeda Pharmaceuticals Co. and Eli Lilly & Co. must face claims that they concealed links between bladder cancer and their diabetes drug Actos, saying the...To view the full article, register now.
Already a subscriber? Click here to view full article